The burden of mental disorders, substance use disorders and self-harm among young people in Europe, 1990–2019: Findings from the Global Burden of Disease Study 2019

Published date: May 2022

Additional Information: Funding Information: Please see appendix section for more detailed information about individual author contributions to the research, divided into the following categories: providing data or critical feedback on data sources; developing methods or computational machinery; providing critical feedback on methods or results; drafting the manuscript or revising it critically for important intellectual content; and managing the overall research enterprise. Members of the core research team for this topic area had full access to the underlying data used to generate estimates presented in this article. All other authors had access to and reviewed estimates as part of the research evaluation process, which includes additional stages of formal review. T W Bärnighausen was supported by the Alexander von Humboldt Foundation through the Alexander von Humboldt Professor award, funded by the German Federal Ministry of Education and Research. F Carvalho acknowledges support from Fundação para a Ciência e a Tecnologia (FCT), I.P. in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of the Research Unit on Applied Molecular Biosciences - UCIBIO and the project LA/P/0140/2020 of the Associate Laboratory Institute for Health and Bioeconomy - i4HB; FCT/MCTES (Ministério da Ciência, Tecnologia e Ensino Superior) through the project UIDB/50006/2020. M Carvalho acknowledges the support from FCT in the scope of the project UIDP/04378/2020 and UIDB/04378/2020 of UCIBIO and the project LA/P/0140/2020 of i4HB. J S Chandan is funded on a lectureship post by the National Institute of Health Research (NIHR) and has been awarded funds from the NIHR and the Youth Endowment Fund. S Dias da Silva acknowledges the projects UIDP/04378/2021 and UIDB/04378/2021 of the Research Unit on Applied Molecular Biosciences–UCIBIO; the project LA/P/0140/2021 of the Associate Laboratory Institute for Health and Bioeconomy–i4HB; and TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, IUCS-CESPU, Portugal. A J Ferrari is supported by a National Health and Medical Research Council Early Career Fellowship Grant APP1121516 and is employed by the Queensland Centre for Mental Health Research which receives core funding from the Queensland Department of Health. S V Katikireddi would like to acknowledge funding from a NRS Senior Clinical Fellowship (SCAF/15/02), the Medical Research Council (MC_UU_00022/2) and the Scottish Government Chief Scientist Office (SPHSU17). J H Kauppila reports research grants from Sigrid Jusélius Foundation and the Finnish Cancer Foundation. M Kivimaki was supported by the Wellcome Trust (221854/Z/20/Z) and the Medical Research Council, UK (MR/R024227/1, MR/S011676/1). M Kumar would like to acknowledge funding support from K43 TW010716-04/NIH Fogarty International Centre. T Lallukka is supported by the Social Insurance Institution of Finland (grant 29/26/2020). J A Loureiro was supported by Fundação para a Ciência e Técnologia (FCT) under the Scientific Employment Stimulus [CEECINST/00049/2018]. J J McGrath was supported by the Danish National Research Foundation (Niels Bohr Professorship), and is employed by The Queensland Centre for Mental Health Research which receives core funding from the Queensland Health. A-F A Mentis would like to acknowledge funding ‘MilkSafe: A novel pipeline to enrich formula milk using omics technologies’, a research co-financed by the European Regional Development Fund of the European Union and Greek national funds through the Operational Program Competitiveness, Entrepreneurship and Innovation, under the call RESEARCH - CREATE - INNOVATE (project code: T2EDK-02222), as well as from ELIDEK (Hellenic Foundation for Research and Innovation, MIMS-860) both outside the submitted work. J P Silva acknowledges support, through Portuguese national funds via FCT/MCTES, from grants number UIDP/04378/2021 and UIDB/04378/2021 of the Research Unit on Applied Molecular Biosciences (UCIBIO), and LA/P/0140/2021 of the Associate Laboratory Institute for Health and Bioeconomy (i4HB). To download the data used in these analyses, please visit the Global Health Data Exchange GBD 2019 website (http://ghdx.healthdata.org/gbd-2019). F M J Postma reports stock or stock options from Health-Ecore and PAG, outside the submitted work. N Steel reports grants from Public Health England to their institution, outside the submitted work. R M Viner reports payment or honoraria for lectures, presentations, speakers bureaus, manuscript writing or educational events from Canadian Academy of Child & Adolescent Psychiatry for lecture on mental health aspects of COVID-19 pandemic; leadership or fiduciary role in other board, society, committee or advocacy group, paid or unpaid, as the President of Royal College of Paediatrics & Child Health, 2018-2021; all outside the submitted work. Publisher Copyright: © 2022 The Author(s)

Keywords: Europe, Mental disorders, Mental health, Self-harm, Substance use, Young people

Local EPrints ID: 475564

URI: http://eprints.soton.ac.uk/id/eprint/475564

DOI: doi:10.1016/j.lanepe.2022.100341

ISSN: 2666-7762

PURE UUID: 9283919d-5665-44ee-9b7c-68e1542ab5e9

ORCID for Paul Lee: orcid.org/0000-0002-5729-6450

Date deposited: 21 Mar 2023 17:46

Last modified: 18 Mar 2024 04:09